The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early ...

Next year will mark a turning point for AI in healthcare as the industry shifts from pilots and hype to accountable, integrated systems that prove to have measurable impact, according to execs.

AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.

Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic ...

The federal grants will support CranioSense’s development and validation of its non-invasive intracranial pressure monitoring ...

Tampa General Hospital Cancer Institute will integrate Reimagine's platform into its clinical pathways to reduce workforce ...

The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise ...

The partnership comes three months after Thyme Care raised $97 million in funding, bringing its total raise to $275 million.

The Order says it revokes attempts to paralyze the AI industry and establishes an AI Litigation Task Force to challenge State ...

ADP participated as a new investor in Thatch's $40 million Series B funding round in April, which brought the company's total ...

Direct-to-consumer telehealth company Hims & Hers is looking to go global with its new acquisition of British personalized health company Honest Health for an undisclosed sum. Founded in 2018, Honest ...